Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.50p
   
  • Change Today:
      0.20p
  • 52 Week High: 9.10p
  • 52 Week Low: 2.40p
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 225,187
  • Market Cap: £24.40m

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
26-Sep-25 Shore Capital House Stock 3.90p - - House Stock
02-Jan-25 Shore Capital House Stock 4.27p - - Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.50p
Change Today 0.20p
% Change 6.06 %
52 Week High 9.10p
52 Week Low 2.40p
Volume 225,187
Shares Issued 697.20m
Market Cap £24.40m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 21-Oct-2025

Time Volume / Share Price
16:06 100,000 @ 3.42p
13:45 3,088 @ 3.46p
11:21 15,000 @ 3.53p
09:52 39,858 @ 3.46p
09:37 270 @ 3.70p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page